Portal:COVID-19/FeaturedPathways
From WikiPathways
Contents |
SARS-CoV-2 Pathways
Image does not exist Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist SARS-CoV-2 includes a novel Orf10 that interacts with multiple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
Image does not exist |
Image does not exist Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist |
Image does not exist Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
Image does not exist Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Other coronaviruses: MERS, SARS-CoV, etc
Image does not exist Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
More about ACE2
Image does not exist |
Image does not exist |
Pathways from Reactome
Image does not exist |
Image does not exist |
List of featured pathways:
- Pathway:WP4846
- Pathway:WP4860
- Pathway:WP4868
- Pathway:WP4927
- Pathway:WP4876
- Pathway:WP4883
- Pathway:WP4891
- Pathway:WP4884
- Pathway:WP4904
- Pathway:WP4936